SLPI and HIV-1 infection: Secretory leukocyte peptidase inhibitor (SLPI) has anti-inflammatory, anti-bacterial, anti-fungal and anti-viral activities77, and its interaction with phospholipid scramblase 1 (PLSCR1) was suggested to inhibit HIV-1 infection of T cells78.